Lutetium Oxodotreotide
ATC — · 4 markets · 6 records
AU 2 records · 2 strengths
- 370 MBq/mLinjectionLUTATHERA lutetium (177Lu) oxodotreotide 370 MBq/mL solution for intravenous infusion vial
Records without a stated strength · 1 Lutathera
HK 2 records · 1 strengths
Records without a stated strength · 1 LUTATHERA SOLUTION FOR INFUSION 370MBQ/ML
SG 1 records · 1 strengths
- 370 MBq/mLinjectionLUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Lutathera
| Strength / form / release | AU | SG | HK | EU |
|---|---|---|---|---|
| 370 MBq/mL injection | LUTATHERA lutetium (177Lu) oxodotreotide 370 MBq/mL solution for intravenous infusion vial | LUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML | ||
unknown | Lutathera | LUTATHERA SOLUTION FOR INFUSION 370MBQ/ML | Lutathera |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.